SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clouseau who wrote ()10/22/1999 5:40:00 PM
From: Bret Masterson  Read Replies (1) of 1029
 
(1)Seems that ICN has been making some good headway lately

(2)Also noticed that Schering Plough reported good earnings, with a 37% increase in Hep C revenues, which as I understand, should lead directly to a 37% increase in ICN royalty payments.

(3)Still looking for $30/share. This board's been pretty quiet of late. Any other opinions on this stock out there?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext